38 related articles for article (PubMed ID: 26036843)
1. Design of Cationic Multiwalled Carbon Nanotubes as Efficient siRNA Vectors for Lung Cancer Xenograft Eradication.
Guo C; Al-Jamal WT; Toma FM; Bianco A; Prato M; Al-Jamal KT; Kostarelos K
Bioconjug Chem; 2015 Jul; 26(7):1370-9. PubMed ID: 26036843
[TBL] [Abstract][Full Text] [Related]
2. Folate-Mediated Targeted Delivery of siPLK1 by Leucine-Bearing Polyethylenimine.
Hou L; Song Z; Xu Z; Wu Y; Shi W
Int J Nanomedicine; 2020; 15():1397-1408. PubMed ID: 32184594
[TBL] [Abstract][Full Text] [Related]
3. Photoactivation of sulfonated polyplexes enables localized gene silencing by DsiRNA in breast cancer cells.
Puri A; Viard M; Zakrevsky P; Zampino S; Chen A; Isemann C; Alvi S; Clogston J; Chitgupi U; Lovell JF; Shapiro BA
Nanomedicine; 2020 Jun; 26():102176. PubMed ID: 32151748
[TBL] [Abstract][Full Text] [Related]
4. Hypoxia-responsive ionizable liposome delivery siRNA for glioma therapy.
Liu HM; Zhang YF; Xie YD; Cai YF; Li BY; Li W; Zeng LY; Li YL; Yu RT
Int J Nanomedicine; 2017; 12():1065-1083. PubMed ID: 28223799
[TBL] [Abstract][Full Text] [Related]
5. Direct cytosolic delivery of siRNA using nanoparticle-stabilized nanocapsules.
Jiang Y; Tang R; Duncan B; Jiang Z; Yan B; Mout R; Rotello VM
Angew Chem Int Ed Engl; 2015 Jan; 54(2):506-10. PubMed ID: 25393227
[TBL] [Abstract][Full Text] [Related]
6. Hyaluronate-coated perfluoroalkyl polyamine prodrugs as bioactive siRNA delivery systems for the treatment of peritoneal cancers.
Yu A; Tang S; Ding L; Foley J; Tang W; Jia H; Panja S; Holbert CE; Hang Y; Stewart TM; Smith LM; Sil D; Casero RA; Oupický D
Biomater Adv; 2022 May; 136():. PubMed ID: 35813988
[TBL] [Abstract][Full Text] [Related]
7. Carbon nanotubes part II: a remarkable carrier for drug and gene delivery.
Karimi M; Solati N; Ghasemi A; Estiar MA; Hashemkhani M; Kiani P; Mohamed E; Saeidi A; Taheri M; Avci P; Aref AR; Amiri M; Baniasadi F; Hamblin MR
Expert Opin Drug Deliv; 2015 Jul; 12(7):1089-105. PubMed ID: 25613837
[TBL] [Abstract][Full Text] [Related]
8. Microglia Determine Brain Region-Specific Neurotoxic Responses to Chemically Functionalized Carbon Nanotubes.
Bussy C; Al-Jamal KT; Boczkowski J; Lanone S; Prato M; Bianco A; Kostarelos K
ACS Nano; 2015 Aug; 9(8):7815-30. PubMed ID: 26043308
[TBL] [Abstract][Full Text] [Related]
9. Carbon nanotubes targeted to the tumor microenvironment inhibit metastasis in a preclinical model of melanoma.
García-Hevia L; Soltani R; González J; Chaloin O; Ménard-Moyon C; Bianco A; L Fanarraga M
Bioact Mater; 2024 Apr; 34():237-247. PubMed ID: 38223536
[TBL] [Abstract][Full Text] [Related]
10. Natural and synthetic nanovectors for cancer therapy.
Eftekhari A; Kryschi C; Pamies D; Gulec S; Ahmadian E; Janas D; Davaran S; Khalilov R
Nanotheranostics; 2023; 7(3):236-257. PubMed ID: 37064613
[TBL] [Abstract][Full Text] [Related]
11. Carbon Nanotubes as Carriers in Drug Delivery for Non-Small Cell Lung Cancer, Mechanistic Analysis of Their Carcinogenic Potential, Safety Profiling and Identification of Biomarkers.
Pu Z; Wei Y; Sun Y; Wang Y; Zhu S
Int J Nanomedicine; 2022; 17():6157-6180. PubMed ID: 36523423
[TBL] [Abstract][Full Text] [Related]
12. Tuning the cationic interface of simple polydiacetylene micelles to improve siRNA delivery at the cellular level.
Hoang MD; Vandamme M; Kratassiouk G; Pinna G; Gravel E; Doris E
Nanoscale Adv; 2019 Nov; 1(11):4331-4338. PubMed ID: 36134419
[TBL] [Abstract][Full Text] [Related]
13. Multistage pH-responsive codelivery liposomal platform for synergistic cancer therapy.
Zhao T; Liang C; Zhao Y; Xue X; Ma Z; Qi J; Shen H; Yang S; Zhang J; Jia Q; Du Q; Cao D; Xiang B; Zhang H; Qi X
J Nanobiotechnology; 2022 Apr; 20(1):177. PubMed ID: 35366888
[TBL] [Abstract][Full Text] [Related]
14. Smart Nanocarriers as an Emerging Platform for Cancer Therapy: A Review.
Kenchegowda M; Rahamathulla M; Hani U; Begum MY; Guruswamy S; Osmani RAM; Gowrav MP; Alshehri S; Ghoneim MM; Alshlowi A; Gowda DV
Molecules; 2021 Dec; 27(1):. PubMed ID: 35011376
[TBL] [Abstract][Full Text] [Related]
15. The Applications of Carbon Nanotubes in the Diagnosis and Treatment of Lung Cancer: A Critical Review.
Sheikhpour M; Naghinejad M; Kasaeian A; Lohrasbi A; Shahraeini SS; Zomorodbakhsh S
Int J Nanomedicine; 2020; 15():7063-7078. PubMed ID: 33061368
[TBL] [Abstract][Full Text] [Related]
16. Applications of Functionalized Carbon Nanotubes for the Therapy and Diagnosis of Cancer.
Hwang Y; Park SH; Lee JW
Polymers (Basel); 2017 Jan; 9(1):. PubMed ID: 30970690
[TBL] [Abstract][Full Text] [Related]
17. Encapsulation and Enhanced Delivery of Topoisomerase I Inhibitors in Functionalized Carbon Nanotubes.
Chae S; Kim D; Lee KJ; Lee D; Kim YO; Jung YC; Rhee SD; Kim KR; Lee JO; Ahn S; Koh B
ACS Omega; 2018 Jun; 3(6):5938-5945. PubMed ID: 30023933
[TBL] [Abstract][Full Text] [Related]
18. Scanning Techniques for Nanobioconjugates of Carbon Nanotubes.
Umemura K; Sato S
Scanning; 2018; 2018():6254692. PubMed ID: 30008981
[TBL] [Abstract][Full Text] [Related]
19. Engineering functional inorganic-organic hybrid systems: advances in siRNA therapeutics.
Shen J; Zhang W; Qi R; Mao ZW; Shen H
Chem Soc Rev; 2018 Mar; 47(6):1969-1995. PubMed ID: 29417968
[TBL] [Abstract][Full Text] [Related]
20. Advanced Functional Nanomaterials for Theranostics.
Huang H; Lovell JF
Adv Funct Mater; 2017 Jan; 27(2):. PubMed ID: 28824357
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
